Now President Giovanni Tomasi sees a newer laser-driven revolution propelling RSL in a range of new directions.
Contracts to supply innovative lighting solutions to the U.S. Navy remain at the heart of the business. RSL’s fiber optic technologies light the masts of several U.S. Navy ships as well as frigates of the Italian navy.
The system solves a variety of problems of traditional electrical connections in hard-to-reach places. It cuts maintenance costs and bypasses cable deterioration concerns.
RSL, which has six employees, has expanded its fiber optic scope to include lighting for areas where hazardous chemicals make traditional lighting dangerous. It also uses fiber optics to measure methane in coal mines and sense temperature changes in a variety of industrial settings.
That’s the strategy employed by Insuritas, an insurance marketing firm based in East Windsor.
Matt Chesky, president and chief operating officer, explains that while insurance is a major, important purchase, it is unique in that both buyer and seller don’t want to interact with each other again. Neither side wants there to be a claim. It’s a “set-it-and-forget-it” transaction.
So, the best way to sell insurance, Chesky says, is to be present at the moment the customer needs to buy it. In the case of homes and cars, that means being at the site of the loan transaction.
Immunotherapies. Vaccines. We’ve all had a crash course in these subjects during this year of the pandemic.
Now a Farmington startup is taking immunotherapies and vaccines in new directions in the battle against disease including COVID-19.
Bijan Almassian is president and CEO at CaroGen Corp. His small team five full-time employees and five part-timers occupies space in UConn Health’s Cell and Genome Building on Farmington Avenue. But much of the firm’s research is going on in laboratories spread across several universities.
CaroGen’s lead product is an immunotherapy that targets Hepatitis B, a viral disease that affects the liver and is spread through bodily fluids. While there are Hep B vaccines on the market, the one CaroGen is working on is for treating chronic Hepatitis B, a disease that afflicts 240 million people worldwide.
What happens when the enhancement is in more demand than the original product?
That was the quandary faced a few years ago by entrepreneurs operating an insurance agency.
And, like all good entrepreneurs, they followed the money, right into a whole new business.
Dino Carbone, executive vice president for sales and marketing at SmartPay Solutions LLC, tells the story of the firm’s inception with reverence.
Those were the days.
The connection between meditation and health dates back centuries. But popular acceptance in this country has been slowed by doubts around “non-scientific” Eastern medical practices and images of New Age incense and crystals.
For the past six years, Cloud 9 Online has been working to gain a solid foothold for meditation within the often-byzantine system of American health care.
The Hartford startup’s concept is a white label personalized meditation therapy program delivered online. The programs are personalized, disease specific and prescribed by physicians.
Progress has come in fits and starts, CEO Delanea Davis explains. She’s a co-founder of Cloud 9, along with Henry Edinger, who serves as chief operation and strategy officer. Both come to the business from the insurance industry.